A carregar...
EphB4/ephrinB2 Contributes to Imatinib Resistance in Chronic Myeloid Leukemia Involved in Cytoskeletal Proteins
Introduction: The mechanism of EphB4/ephrinB2 in the resistance of chronic myelogenous leukemia to imatinib keeps unknown. Methods: The imatinib resistant chronic myelogenous leukemia cell line-K562-R, was established. EphB4 receptor expression was detected in patients and resistant cells. Cell migr...
Na minha lista:
Publicado no: | Int J Med Sci |
---|---|
Main Authors: | , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Ivyspring International Publisher
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4879769/ https://ncbi.nlm.nih.gov/pubmed/27226777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.14989 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|